Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Sanofi

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sanofi's 2013 sales performance.

Sanofi

EIT Health launches the WorkInHealth Foundation

EIT Health launches the WorkInHealth Foundation It will seek sponsorship from its existing partners, including Atos and Sanofi, alongside garnering support from bigger tech corporations like Apple, Microsoft and Amazon.

Sanofi’s asthma treatment approved by European Commission

Sanofi’s asthma treatment approved by European Commission Naimish Patel is head of global development, Immunology and Inflammation at Sanofi, and spoke about bringing the well-established safety and efficacy of Dupixent to an even younger group of patients

Sanofi launches Diversity, Equity & Inclusion Board

Sanofi launches Diversity, Equity & Inclusion Board Sanofi has launched a Diversity, Equity &Inclusion (DE&I) Board. The Board will feature outside advisors, a first in the pharmaceutical industry. ... Paul Hudson, CEO of Sanofi, said: “We’re committed to driving diversity, equity and inclusion in

Sanofi and IGM Biosciences agree on deal potentially worth over $6bn

Sanofi and IGM Biosciences agree on deal potentially worth over $6bn development, regulatory and commercial milestones. Sanofi has also expressed an interest in buying up to $100m of IGM non-voting common stock. ... This partnership builds on an existing research collaboration with Sanofi and is a key step towards.

Sanofi and Regeneron share positive trial results for patients with uncontrolled prurigo nodularis

Sanofi and Regeneron share positive trial results for patients with uncontrolled prurigo nodularis Positive results from the phase 3 PRIME2 trial – part of the LIBERTY-PN PRIME clinical programme – assessing the safety and effectiveness of Sanofi and Regeron’s Dupixent (dupilumab) were shared in ... Previously, Sanofi and Regeneron announced

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...